Sparsh bio-tech

Jamnagar, India Founded: 2004 • Age: 22 yrs
Manufacturing and exporting of pharmaceuticals, focusing on dosage forms like capsules and tablets.
Annual revenue $56.9M Latest available
Total funding - Funding intelligence
Employees 202 Tracked headcount
Investors - Known backers
Products 2 Services tracked
Competitors - Brand Intelligence

About Sparsh bio-tech

Sparsh bio-tech is a company based in Jamnagar (India) founded in 2004. The company has 202 employees as of April 05, 2024. Sparsh bio-tech offers products and services including Amoxicillin and Ampicillin.

  • Headquarter Jamnagar, India
  • Employees 202 as on 05 Apr, 2024
  • Sectors
    Healthcare
  • Email
    Locked
  • Phone
    Locked
  • Social
    Locked
  • Legal Name Sparsh Bio-Tech Private Limited
  • Date of Incorporation 30 Mar, 2001
  • Jurisdiction Jamnagar, Gujarat, India
Operational Areas
Healthcare → Pharmaceuticals & Therapeutics Unlock Sub-Sector Unlock Segment
Healthcare → Healthcare Products & Supplies Unlock Sub-Sector Unlock Segment
Key Metrics
  • Annual Revenue
    $56.89 M (USD)
    8.34
    as on Mar 31, 2024
  • Net Profit
    $2.99 M (USD)
    17.7
    as on Mar 31, 2024
  • EBITDA
    $4.4 M (USD)
    23.79
    as on Mar 31, 2024
  • Latest Funding Round
    Not available
  • Investors
    Not available
  • Employee Count
    202

    as on Apr 05, 2024

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Products & Services of Sparsh bio-tech

Sparsh bio-tech offers a comprehensive portfolio of products and services, including Amoxicillin and Ampicillin.

Product name locked
Category locked
Primary

Amoxicillin is produced as an antibiotic in capsule form for human health applications.

Product name locked
Category locked
Locked

Ampicillin is manufactured as an antibiotic medication in various dosage forms.

Funding Insights of Sparsh bio-tech

Premium access

Detailed funding history for Sparsh bio-tech

Round names, dates, amounts, investors, and valuation history require an active premium plan.

  • Round names and dates
  • Funding amounts
  • Participating investors
  • Valuation history

Verified entity values are shown only after access is granted.

Investments & Acquisitions by Sparsh bio-tech

Investments
Premium access

Investment portfolio details for Sparsh bio-tech

Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.

  • Portfolio identities
  • Transaction dates
  • Round details
  • Investment values

Verified entity values are shown only after access is granted.

Financial Statements - Sparsh bio-tech

Premium access

Detailed financials for Sparsh bio-tech

Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.

  • Historical revenue
  • Profit trends
  • Statement rows
  • Financial ratios

Verified entity values are shown only after access is granted.

Sparsh Bio-Tech Comparisons

Sparsh bio-tech Primary company
Description
Manufacturing and exporting of pharmaceuticals, focusing on ...
Location
Jamnagar, India
Founded Year
2004
Annual Revenue
$56.89 M (USD)
Net Profit
$2.99 M (USD)
EBITDA
$4.4 M (USD)
Employees
202
As of 2024
Premium access

Peer comparison for Sparsh bio-tech

Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.

  • Named peers
  • Headcount comparison
  • Funding comparison
  • Operating benchmarks

Verified entity values are shown only after access is granted.

+
Add Comparison
Available on Premium

Competitors of Sparsh bio-tech

Premium access

Detailed competitors of Sparsh bio-tech

Competitor domains, locations, full profiles, and operating metrics require an active premium plan.

  • Domains and locations
  • Full company profiles
  • Operating metrics
  • Competitive positioning

Verified entity values are shown only after access is granted.

Latest news on Sparsh Bio-Tech

Premium access

Complete news archive for Sparsh bio-tech

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Sparsh bio-tech

Sparsh bio-tech was founded in 2004.

Sparsh bio-tech is headquartered in Jamnagar, India. It is registered at Jamnagar, Gujarat, India.

As of Apr 05, 2024, the latest employee count at Sparsh bio-tech is 202.

Annual revenue of Sparsh bio-tech is $56.89M as on Mar 31, 2024.

Sparsh Bio-Tech is recognized as a pharmaceutical manufacturer and exporter based in Jamnagar, Gujarat, India, where a dedicated Betalactum plant is operated for producing dosage forms such as capsules, tablets, and dry syrups. Quality management systems are employed to ensure that medicines are developed and delivered to meet humanitarian needs, emphasizing safety, efficacy, and cost-effectiveness. The organization is noted for navigating technical and regulatory complexities in the market, while financial and logistical aspects are managed effectively to support its operations and presence in the pharmaceutical sector.

Sparsh bio-tech offers Amoxicillin and Ampicillin.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available